ArticleMagma (New York, N.Y.)2022

GLINT: GlucoCEST in neoplastic tumors at 3 T-clinical results of GlucoCEST in gliomas.

Benjamin Bender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.